Page 48 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delaying or stopping STEMI treatment during the first COVID-19-related lockdown in England was associated with approximately 2 life-years lost per patient vs. pre-lockdown conditions, according to a modeling analysis presented at EuroPCR.In an analysis to predict the potential clinical and economic burden associated with reductions in PCI treatment access during the COVID-19 lockdown in England,

Peer-reviewed papers on pediatric antiphospholipid syndrome do not appear very often.However, when they do, they can be incredibly useful for rheumatologists who find themselves trying to diagnose and manage a patient with this rare and complicated condition, which can present in myriad ways.

The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms in adults with high pain sensitivity, according to a company press release.“There is an unmet need for effective and safe fibromyalgia treatments,” Shai N. Gozani, MD, PhD, CEO of NeuroMetrix, said in the release. “Receiving this De

ATLANTA – A no-implant interatrial shunt improved HF symptoms including exercise capacity, quality of life and NYHA class at 3 and 6 months, a speaker reported.At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, Colin M. Barker, MDI, FSCAI, director of the cardiac catheterization laboratory at Vanderbilt University Medical Center in Nashville, Tennessee,

The National Kidney Foundation announced it has entered a partnership with the American Society of Transplantation’s Living Donor Circle of Excellence program.According to a press release, the Circle of Excellence is designed to increase the number living organ donors by acknowledging employers that supply lost wages while donors recover from surgery. To join the Circle of Excellence,